EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Registry‐Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021–2024

Elina Seppälä iD, Håkon Bøås iD, Jesper Dahl iD, Jeanette Stålcrantz iD, Melanie Stecher, Ragnhild Tønnessen iD, Gunnar Øyvind Isaksson Rø, Hilde Kløvstad, Trine Hessevik Paulsen

Influenza and Other Respiratory Viruses · 2025

DOI: 10.1111/irv.70080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2025. Verfasst von Elina Seppälä und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway. Hauptthemen laut MEDLINE: Registries, Respiratory Tract Infections, COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Centre for Disease Prevention and Control.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In 2021, the Norwegian Institute of Public Health established temporary registry‐based surveillance of severe acute respiratory infections (SARI). We aimed to describe the surveillance system and evaluate selected attributes to inform the establishment of a permanent SARI surveillance system.

Methods

SARI cases were defined using ICD‐10 discharge codes from national health and administrative registries, including codes for acute upper or lower respiratory infection (URI and LRI), COVID‐19, acute respiratory distress syndrome, pertussis or otitis media. Data from polymerase chain reaction (PCR) analyses were available for 10 respiratory pathogens including SARS‐CoV‐2, influenza virus and respiratory syncytial virus (RSV). We included data from 28 September 2020 to 31 March 2024 and calculated the following parameters: the proportion of cases tested for SARS‐CoV‐2, influenza virus and/or RSV; time between admission and registration of a SARI‐related ICD‐10 code; and proportion of cases with URI, LRI and COVID‐19.

Results

We identified 214,730 SARI cases, of whom 82%, 73% and 53% were tested for SARS‐CoV‐2, influenza virus and RSV. Case peaks were predominantly driven by one or a combination of these pathogens. Median time between admission and a registered SARI diagnostic code was 5 (lower–upper quartile 3–10) days. Nowcasting and alternative case definitions for SARI with COVID‐19, influenza and RSV improved the timeliness. The ICD‐10 codes for LRIs and COVID‐19 captured only ~55% of the cases in the age group of 0–29 years compared to the routine case definition, where URIs were included.

Conclusions

Registry‐based SARI surveillance provides timely data for handling epidemics of respiratory infections in Norway. We recommend establishing a permanent SARI surveillance system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesRespiratory Tract InfectionsCOVID-19HumansNorwayAdultFemaleMaleMiddle AgedInfantChildChild, PreschoolAgedAdolescentYoung AdultInfluenza, HumanSARS-CoV-2Infant, NewbornRespiratory Syncytial Virus InfectionsEpidemiological MonitoringAged, 80 and over

Stichwörter der Autor:innen

COVID‐19RSVhospitalisationinfluenzaregistry‐based surveillancesevere acute respiratory infection (SARI)

Autor:innen und Institutionen

  • Department of Infectious Disease Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
  • ECDC Fellowship Programme, Field Epidemiology Path (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Department of Analysis and Diagnostics, Norwegian Veterinary Institute, Ås, Norway.
  • Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.

ORCID-Profile: Elina Seppälä, Håkon Bøås, Jesper Dahl, Jeanette Stålcrantz, Ragnhild Tønnessen

Förderung

  • European Centre for Disease Prevention and Control

Zitieren

APA

Seppälä, E., Bøås, H., Dahl, J., Stålcrantz, J., Stecher, M., Tønnessen, R., Rø, G. Ø. I., Kløvstad, H., & Paulsen, T. H. (2025). Registry‐Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021–2024. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70080

Vancouver

Seppälä E, Bøås H, Dahl J, Stålcrantz J, Stecher M, Tønnessen R, et al. Registry‐Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021–2024. Influenza and Other Respiratory Viruses. 2025. doi:10.1111/irv.70080

BibTeX
@article{Seppl2025,
  author = {Seppälä, Elina and Bøås, Håkon and Dahl, Jesper and Stålcrantz, Jeanette and Stecher, Melanie and Tønnessen, Ragnhild and Rø, Gunnar Øyvind Isaksson and Kløvstad, Hilde and Paulsen, Trine Hessevik},
  title = {Registry‐Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021–2024},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2025},
  doi = {10.1111/irv.70080}
}
Kostenlos starten →